In light of the pro-tumorigenic and immunosuppressive functions of TLR2 discussed in the previous paragraphs, we suggest that TLR2 may act as a double-edge sword in cancer therapy and that the use of TLR2 agonists in cancer treatment should be carefully evaluated, since it could potentiate cancer cell growth and immunosuppressive mechanisms. Here, TLR2 is linked to cancer.